Literature DB >> 30723518

Do Optic Canal Dimensions Measured on CT Influence the Degree of Papilloedema and Visual Dysfunction in Idiopathic Intracranial Hypertension?

Nicholas T Skipper1, Mark S Igra1, Revelle Littlewood2, Paul Armitage3, Peter J Laud4, Susan P Mollan5, Basil Sharrack6,7, Irene M Pepper2, Ruth Batty1, Daniel J A Connolly1, Simon J Hickman6.   

Abstract

A recent study found that increased optic canal area on magnetic resonance imaging was associated with worse papilloedema in idiopathic intracranial hypertension (IIH). We repeated this study using more accurate computerized tomography derived measurements. Optic canal dimensions were measured from 42 IIH patients and 24 controls.  These were compared with papilloedema grade.  There was no correlation between any of the optic canal measurements and papilloedema grade and no significant difference in optic canal measurements between patients and controls. Our results cast doubt on the existing literature regarding the association between optic canal size and the degree of papilloedema in IIH. CT delineates bony anatomy more accurately than MRI and our CT-derived optic canal measurements cast doubt on the existing literature regarding the association between optic canal size and the degree of Papilloedema in IIH.

Entities:  

Keywords:  Papilloedema; idiopathic intracranial hypertension; optic canal; pesudotumour cerebri

Year:  2018        PMID: 30723518      PMCID: PMC6351014          DOI: 10.1080/01658107.2018.1483406

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  19 in total

Review 1.  Diagnostic criteria for idiopathic intracranial hypertension.

Authors:  Deborah I Friedman; Daniel M Jacobson
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

2.  PATHOGENESIS OF OEDEMA OF THE OPTIC DISC (PAPILLOEDEMA). A PRELIMINARY REPORT.

Authors:  S S HAYREH
Journal:  Br J Ophthalmol       Date:  1964-10       Impact factor: 4.638

Review 3.  Compartmentalized cerebrospinal fluid.

Authors:  Hanspeter E Killer; Prem S Subramanian
Journal:  Int Ophthalmol Clin       Date:  2014

4.  Unilateral papilledema in pseudotumor cerebri.

Authors:  K W To; F A Warren
Journal:  Arch Ophthalmol       Date:  1990-05

5.  Intracanalicular Optic Nerve Swelling and Signal Change in Fulminant Untreated Idiopathic Intracranial Hypertension.

Authors:  Anand A Moodley; Mahlubonke S Dlwati; Miranda Durand
Journal:  Neuroophthalmology       Date:  2016-12-20

6.  Reduced Free Communication of the Subarachnoid Space Within the Optic Canal in the Human.

Authors:  Mikee Liugan; Zhaoyang Xu; Ming Zhang
Journal:  Am J Ophthalmol       Date:  2017-04-26       Impact factor: 5.258

7.  Architecture of arachnoid trabeculae, pillars, and septa in the subarachnoid space of the human optic nerve: anatomy and clinical considerations.

Authors:  H E Killer; H R Laeng; J Flammer; P Groscurth
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

8.  Unilateral disk edema in a young woman.

Authors:  M L Moster; M Slavin; M Wall
Journal:  Surv Ophthalmol       Date:  1995 Mar-Apr       Impact factor: 6.048

9.  Magnetic resonance imaging in pseudotumor cerebri.

Authors:  M C Brodsky; M Vaphiades
Journal:  Ophthalmology       Date:  1998-09       Impact factor: 12.079

10.  The Optic Canal Size Is Associated With the Severity of Papilledema and Poor Visual Function in Idiopathic Intracranial Hypertension.

Authors:  Samuel Bidot; Lindsay Clough; Amit M Saindane; Nancy J Newman; Valérie Biousse; Beau B Bruce
Journal:  J Neuroophthalmol       Date:  2016-06       Impact factor: 3.042

View more
  2 in total

1.  Posterior Globe Flattening without Papilledema in Idiopathic Intracranial Hypertension.

Authors:  Jonathan A Micieli
Journal:  Neuroophthalmology       Date:  2019-06-19

Review 2.  Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema.

Authors:  Susan P Mollan; Yu Jeat Chong; Olivia Grech; Alex J Sinclair; Benjamin R Wakerley
Journal:  Life (Basel)       Date:  2021-05-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.